Two Henkel Facilities Certified as Pharmaceutical Excipients Suppliers
Henkel recently announced that two of the company’s facilities have received EXCiPACT certificates as suppliers of pharmaceutical excipients. With more than 60 years of experience in polymerization, Henkel Adhesive Technologies is a leading global provider of acrylic polymers for transdermal drug delivery. This comprehensive know-how has now been recognized with a quality seal for the second time. Henkel’s Salisbury, North Carolina, facility has now received the EXCiPACT certificate. The company’s Drogenbos site in Belgium has been EXCiPACT-certified since 2021.
The certificate awarded by the non-profit organization EXCiPACT attests that adhesives are manufactured and distributed as pharmaceutical excipients at the Henkel facilities in Salisbury and Drogenbos in accordance with EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP). EXCiPACT offers an independent, high-quality certification system specifically for this area of the pharmaceutical industry. It is accepted by all important stakeholders, including the EU, the U.S. Food and Drug Administration, and the British Medicines and Healthcare products Regulatory Agency (MHRA).